Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
- March -
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
- 2005 -
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
March 2005 - 19 products
Ph
Carmol Bonbons contre la
toux
75 g
PR
PR
k.A.
Bonbons: 10 Active Agents
VERFORA SA
E
FB
G
L
IP
CI
Tarceva 100 mg
30 Tablet(s)
1733.91
1965.10
10 %
Coated tablets: Erlotinibum 100 mg
Roche Pharma
(Schweiz) AG
A / SL / SO
FB
G
L
IP
CI
Tarceva 150 mg
30 Tablet(s)
2064.16
2327.65
10 %
Coated tablets: Erlotinibum 150 mg
Roche Pharma
(Schweiz) AG
A / SL / SO
FB
G
IP
CI
Zolpidem Spirig HC 10 mg
10
1.65
6.00
10 %
Coated tablets: Zolpidemi Tartras 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Zolpidem Spirig HC 10 mg
30
4.98
9.85
10 %
Coated tablets: Zolpidemi Tartras 10 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
A
Zolpidem Streuli
10 Tablet(s)
1.75
6.10
10 %
Coated tablets: Zolpidemi Tartras 10 mg
Streuli Pharma AG
B / SL / SG
FB
G
IP
CI
A
Zolpidem Streuli
30 Tablet(s)
4.99
9.85
10 %
Coated tablets: Zolpidemi Tartras 10 mg
Streuli Pharma AG
B / SL / SG
FB
G
IP
CI
Zolpidem-Mepha Teva 10
10
1.62
5.95
10 %
Coated tablets: Zolpidemi Tartras 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Zolpidem-Mepha Teva 10
30
4.96
9.80
10 %
Coated tablets: Zolpidemi Tartras 10 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Tineafin 250 mg
14 Tablet(s)
25.06
45.20
10 %
Tablets: Terbinafinum 250 mg
Bailleul (Suisse) SA
B / SL / SG
FB
G
IP
CI
Tineafin 250 mg
28 Tablet(s)
53.09
77.40
10 %
Tablets: Terbinafinum 250 mg
Bailleul (Suisse) SA
B / SL / SG
FB
G
L
IP
CI
Adartrel 0,25 mg
12 Tablet(s)
3.19
7.75
10 %
Coated tablets: Ropinirolum
GlaxoSmithKline AG
B / SL
FB
G
L
IP
CI
Adartrel 0,5 mg
84 Tablet(s)
17.69
36.75
10 %
Coated tablets: Ropinirolum
GlaxoSmithKline AG
B / SL
FB
G
L
IP
CI
Adartrel 2,0 mg
84 Tablet(s)
58.02
83.10
10 %
Coated tablets: Ropinirolum 2 mg
GlaxoSmithKline AG
●
B / SL
FB
G
IP
Plasma-Lyte A
20 x 500 ml
PR
PR
k.A.
Infusion solution: 5 Active Agents
Baxter AG
B
FB
G
IP
Plasma-Lyte A
10 x 1000 ml
PR
PR
k.A.
Infusion solution: 5 Active Agents
Baxter AG
B
FB
G
IP
CI
Tarceva 25 mg
30 Tablet(s)
PR
PR
k.A.
Coated tablets: Erlotinibum 25 mg
Roche Pharma
(Schweiz) AG
A
FB
G
IP
CI
A
Zolpidem Streuli
100 Tablet(s)
PR
PR
k.A.
Coated tablets: Zolpidemi Tartras 10 mg
Streuli Pharma AG
B
FB
G
IP
CI
Tineafin 125 mg
14 Tablet(s)
15.00
34.05
k.A.
Tablets: Terbinafinum 125 mg
Bailleul (Suisse) SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
